(aminomethyl)phosphonic acid multiple interactions ISO RGD:1347209 6480464 [1-aminomethylphosphonic acid co-treated with methoxyacetic acid] results in decreased expression of BIRC2 protein CTD PMID:26006246 (S)-nicotine multiple interactions ISO RGD:1347209 6480464 Curcumin inhibits the reaction [Nicotine results in increased expression of BIRC2 protein] CTD PMID:20727180 (S)-nicotine increases expression ISO RGD:1347209 6480464 Nicotine results in increased expression of BIRC2 protein CTD PMID:20727180 1'-acetoxychavicol acetate multiple interactions ISO RGD:1347209 6480464 1'-acetoxychavicol acetate inhibits the reaction [TNF protein results in increased expression of BIRC2 protein] CTD PMID:15905586 1,2-dichloroethane decreases expression ISO RGD:732625 6480464 ethylene dichloride results in decreased expression of BIRC2 mRNA CTD PMID:28960355 1,3-dinitrobenzene decreases expression EXP 6480464 3-dinitrobenzene results in decreased expression of BIRC2 mRNA CTD PMID:22841810 , PMID:24140754 15-deoxy-Delta(12,14)-prostaglandin J2 decreases expression ISO RGD:1347209 6480464 15-deoxy-delta(12, 14)-prostaglandin J2 results in decreased expression of BIRC2 protein CTD PMID:15498850 17beta-estradiol affects expression ISO RGD:732625 6480464 Estradiol affects the expression of BIRC2 mRNA CTD PMID:15598610 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of BIRC2 mRNA CTD PMID:26496021 17beta-estradiol affects expression ISO RGD:1347209 6480464 Estradiol affects the expression of BIRC2 mRNA CTD PMID:21826169 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:1347209 6480464 2 more ... CTD PMID:27589474 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:732625 6480464 Tetrachlorodibenzodioxin results in increased expression of BIRC2 mRNA CTD PMID:12167310 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:732625 6480464 Tetrachlorodibenzodioxin affects the expression of BIRC2 mRNA CTD PMID:21570461 , PMID:26377647 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of BIRC2 mRNA CTD PMID:21346803 2-methylcholine affects expression ISO RGD:1347209 6480464 beta-methylcholine affects the expression of BIRC2 mRNA CTD PMID:21179406 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1347209 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of BIRC2 mRNA CTD PMID:28628672 3-phenylprop-2-enal multiple interactions ISO RGD:1347209 6480464 Vitamin E inhibits the reaction [cinnamic aldehyde results in decreased expression of BIRC2 protein] CTD PMID:15566391 3-phenylprop-2-enal decreases expression ISO RGD:1347209 6480464 cinnamic aldehyde results in decreased expression of BIRC2 protein CTD PMID:15566391 4-aminopyridine decreases expression EXP 6480464 4-Aminopyridine results in decreased expression of BIRC2 mRNA CTD PMID:24378259 4-hydroxyphenyl retinamide multiple interactions ISO RGD:1347209 6480464 Fenretinide inhibits the reaction [TNF protein results in increased expression of BIRC2 protein] CTD PMID:16230421 4-hydroxyphenyl retinamide decreases expression ISO RGD:1347209 6480464 Fenretinide results in decreased expression of BIRC2 protein CTD PMID:16230421 4-hydroxyphenyl retinamide increases expression ISO RGD:732625 6480464 Fenretinide results in increased expression of BIRC2 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine affects expression ISO RGD:1347209 6480464 Decitabine affects the expression of BIRC2 protein CTD PMID:18636160 5-fluorouracil increases expression ISO RGD:1347209 6480464 Fluorouracil results in increased expression of BIRC2 mRNA CTD PMID:17039268 acrolein multiple interactions ISO RGD:1347209 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Acrolein results in increased expression of BIRC2 protein] more ... CTD PMID:19596284 acrolein increases expression ISO RGD:1347209 6480464 Acrolein results in increased expression of BIRC2 protein CTD PMID:19596284 adenosine decreases expression ISO RGD:1347209 6480464 Adenosine results in decreased expression of BIRC2 mRNA, Adenosine results in decreased expression of BIRC2 protein CTD PMID:20063052 aflatoxin B1 increases expression ISO RGD:732625 6480464 Aflatoxin B1 results in increased expression of BIRC2 mRNA CTD PMID:19770486 aflatoxin B1 decreases methylation ISO RGD:1347209 6480464 Aflatoxin B1 results in decreased methylation of BIRC2 gene CTD PMID:27153756 all-trans-retinoic acid multiple interactions ISO RGD:1347209 6480464 [Tretinoin co-treated with Paclitaxel] results in decreased expression of BIRC2 protein more ... CTD PMID:16140955 more ... all-trans-retinoic acid decreases expression ISO RGD:1347209 6480464 Tretinoin results in decreased expression of BIRC2 protein CTD PMID:17701358 , PMID:18098270 all-trans-retinoic acid decreases expression ISO RGD:732625 6480464 Tretinoin results in decreased expression of BIRC2 mRNA CTD PMID:16604517 all-trans-retinoic acid increases expression ISO RGD:1347209 6480464 Tretinoin results in increased expression of BIRC2 mRNA CTD PMID:16140955 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of BIRC2 mRNA CTD PMID:16483693 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of BIRC2 mRNA CTD PMID:30779732 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:1347209 6480464 pyrazolanthrone promotes the reaction [IL1A protein results in increased expression of BIRC2 mRNA] CTD PMID:12832416 apigenin multiple interactions ISO RGD:1347209 6480464 [TNFSF10 protein results in increased susceptibility to Apigenin] which results in decreased expression of BIRC2 protein CTD PMID:29247770 aprepitant multiple interactions ISO RGD:1347209 6480464 Arsenic Trioxide promotes the reaction [Aprepitant results in decreased expression of BIRC2 mRNA] CTD PMID:30145367 aprepitant decreases expression ISO RGD:1347209 6480464 Aprepitant results in decreased expression of BIRC2 mRNA CTD PMID:30145367 arsenite(3-) multiple interactions ISO RGD:1347209 6480464 XPA protein affects the reaction [arsenite results in increased expression of BIRC2 mRNA] CTD PMID:18585952 arsenite(3-) decreases expression ISO RGD:732625 6480464 arsenite results in decreased expression of BIRC2 mRNA CTD PMID:18191166 arsenite(3-) increases expression ISO RGD:1347209 6480464 arsenite results in increased expression of BIRC2 mRNA CTD PMID:18585952 arsenous acid multiple interactions ISO RGD:1347209 6480464 [NVP-BKM120 co-treated with Arsenic Trioxide] results in decreased expression of BIRC2 mRNA, Arsenic Trioxide promotes the reaction [Aprepitant results in decreased expression of BIRC2 mRNA] CTD PMID:30145367 , PMID:30316766 beauvericin increases expression ISO RGD:1347209 6480464 beauvericin results in increased expression of BIRC2 mRNA CTD PMID:29203277 benzo[a]pyrene increases expression ISO RGD:732625 6480464 Benzo(a)pyrene results in increased expression of BIRC2 mRNA CTD PMID:22228805 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1347209 6480464 7 more ... CTD PMID:19150397 bisphenol A affects expression ISO RGD:1347209 6480464 bisphenol A affects the expression of BIRC2 mRNA CTD PMID:21826169 bisphenol A decreases expression ISO RGD:1347209 6480464 bisphenol A results in decreased expression of BIRC2 mRNA CTD PMID:29275510 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of BIRC2 mRNA CTD PMID:25181051 , PMID:30816183 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of BIRC2 mRNA CTD PMID:26496021 bisphenol A increases expression ISO RGD:732625 6480464 bisphenol A results in increased expression of BIRC2 mRNA CTD PMID:23704952 bisphenol F multiple interactions ISO RGD:1347209 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of BIRC2 mRNA CTD PMID:28628672 bleomycin A2 decreases response to substance ISO RGD:1347209 6480464 BIRC2 protein results in decreased susceptibility to Bleomycin CTD PMID:10815900 bleomycin A2 increases expression EXP 6480464 Bleomycin results in increased expression of BIRC2 protein CTD PMID:15371238 bortezomib decreases expression ISO RGD:1347209 6480464 Bortezomib results in decreased expression of BIRC2 protein CTD PMID:15543232 , PMID:17626072 bortezomib multiple interactions ISO RGD:1347209 6480464 [geldanamycin co-treated with Bortezomib] results in decreased expression of BIRC2 protein, [romidepsin co-treated with Bortezomib] results in decreased expression of BIRC2 protein CTD PMID:15781649 , PMID:18223231 cadmium atom increases expression ISO RGD:1347209 6480464 Cadmium results in increased expression of BIRC2 protein CTD PMID:14647439 cadmium atom decreases expression EXP 6480464 Cadmium results in decreased expression of BIRC2 protein CTD PMID:16478757 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of BIRC2 protein CTD PMID:16478757 calcitriol decreases expression ISO RGD:1347209 6480464 Calcitriol results in decreased expression of BIRC2 protein CTD PMID:12479363 capsaicin increases expression ISO RGD:1347209 6480464 Capsaicin results in increased expression of BIRC2 mRNA CTD PMID:19502594 carboplatin decreases response to substance ISO RGD:1347209 6480464 BIRC2 protein results in decreased susceptibility to Carboplatin CTD PMID:10815900 chlorambucil decreases response to substance ISO RGD:1347209 6480464 BIRC2 protein results in decreased susceptibility to Chlorambucil CTD PMID:10815900 chlorpromazine decreases expression ISO RGD:1347209 6480464 Chlorpromazine results in decreased expression of BIRC2 mRNA CTD PMID:30703373 chrysazin decreases expression ISO RGD:1347209 6480464 danthron results in decreased expression of BIRC2 protein CTD PMID:21126053 Cinobufagin decreases expression ISO RGD:1347209 6480464 cinobufagin results in decreased expression of BIRC2 protein CTD PMID:23164673 cisplatin decreases response to substance ISO RGD:1347209 6480464 BIRC2 protein results in decreased susceptibility to Cisplatin CTD PMID:10815900 more ... crizotinib decreases expression ISO RGD:1347209 6480464 crizotinib results in decreased expression of BIRC2 protein CTD PMID:22729845 crizotinib multiple interactions ISO RGD:1347209 6480464 MET gene mutant form promotes the reaction [crizotinib results in increased expression of BIRC2 protein] CTD PMID:22729845 curcumin decreases expression ISO RGD:1347209 6480464 Curcumin analog results in decreased expression of BIRC2 mRNA more ... CTD PMID:16023083 more ... curcumin multiple interactions ISO RGD:1347209 6480464 Curcumin inhibits the reaction [Nicotine results in increased expression of BIRC2 protein] more ... CTD PMID:16219905 more ... cyclosporin A increases expression ISO RGD:1347209 6480464 Cyclosporine results in increased expression of BIRC2 mRNA CTD PMID:20106945 cypermethrin increases expression ISO RGD:1347209 6480464 cypermethrin results in increased expression of BIRC2 mRNA CTD PMID:27704156 dexamethasone multiple interactions ISO RGD:1347209 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of BIRC2 mRNA, Dexamethasone inhibits the reaction [TNF protein results in decreased expression of BIRC2 protein] CTD PMID:11399663 , PMID:28628672 diallyl trisulfide increases expression ISO RGD:1347209 6480464 diallyl trisulfide results in increased expression of BIRC2 protein CTD PMID:21411500 diallyl trisulfide decreases expression ISO RGD:1347209 6480464 diallyl trisulfide results in decreased expression of BIRC2 protein CTD PMID:22578287 diarsenic trioxide multiple interactions ISO RGD:1347209 6480464 [NVP-BKM120 co-treated with Arsenic Trioxide] results in decreased expression of BIRC2 mRNA, Arsenic Trioxide promotes the reaction [Aprepitant results in decreased expression of BIRC2 mRNA] CTD PMID:30145367 , PMID:30316766 dicrotophos decreases expression ISO RGD:1347209 6480464 dicrotophos results in decreased expression of BIRC2 mRNA CTD PMID:28302478 diosgenin multiple interactions ISO RGD:1347209 6480464 Diosgenin inhibits the reaction [TNF protein results in increased expression of BIRC2 protein] CTD PMID:16331273 diosgenin decreases expression ISO RGD:1347209 6480464 Diosgenin results in decreased expression of BIRC2 protein CTD PMID:16331273 dioxygen multiple interactions ISO RGD:1347209 6480464 3 more ... CTD PMID:23452621 dioxygen increases expression ISO RGD:1347209 6480464 Oxygen deficiency results in increased expression of BIRC2 mRNA, Oxygen deficiency results in increased expression of BIRC2 protein CTD PMID:23452621 disodium selenite decreases expression ISO RGD:732625 6480464 Sodium Selenite results in decreased expression of BIRC2 protein CTD PMID:14737004 disodium selenite increases expression ISO RGD:1347209 6480464 Sodium Selenite results in increased expression of BIRC2 mRNA CTD PMID:16705456 doxorubicin increases expression ISO RGD:1347209 6480464 Doxorubicin results in increased expression of BIRC2 mRNA, Doxorubicin results in increased expression of BIRC2 protein CTD PMID:14666661 more ... doxorubicin multiple interactions ISO RGD:1347209 6480464 Sirolimus inhibits the reaction [Doxorubicin results in increased expression of BIRC2 protein] CTD PMID:15571967 doxorubicin decreases expression ISO RGD:1347209 6480464 Doxorubicin results in decreased expression of BIRC2 protein CTD PMID:15359644 doxorubicin affects response to substance ISO RGD:1347209 6480464 BIRC2 protein affects the susceptibility to Doxorubicin CTD PMID:14666661 , PMID:16217747 elemental selenium multiple interactions EXP 6480464 [Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of BIRC2 mRNA CTD PMID:11444866 ethanol multiple interactions ISO RGD:1347209 6480464 Ethanol inhibits the reaction [FOXO3 protein results in increased expression of BIRC2 mRNA] CTD PMID:26470730 etodolac increases activity ISO RGD:1347209 6480464 Etodolac results in increased activity of BIRC2 protein CTD PMID:16046235 etodolac decreases expression ISO RGD:1347209 6480464 Etodolac results in decreased expression of BIRC2 protein CTD PMID:16104877 etoposide affects response to substance ISO RGD:1347209 6480464 BIRC2 protein affects the susceptibility to Etoposide CTD PMID:16217747 etoposide decreases response to substance ISO RGD:1347209 6480464 BIRC2 protein results in decreased susceptibility to Etoposide CTD PMID:10815900 , PMID:15050749 etoposide increases expression ISO RGD:1347209 6480464 Etoposide results in increased expression of BIRC2 mRNA CTD PMID:14970392 Evodiamine multiple interactions ISO RGD:1347209 6480464 evodiamine inhibits the reaction [TNF protein results in increased expression of BIRC2 protein] CTD PMID:15710601 flavonoids decreases expression EXP 6480464 Flavonoids results in decreased expression of BIRC2 mRNA CTD PMID:18035473 folic acid increases expression ISO RGD:1347209 6480464 Folic Acid results in increased expression of BIRC2 mRNA, Folic Acid results in increased expression of BIRC2 protein CTD PMID:15211800 folic acid multiple interactions EXP 6480464 [Carbon Tetrachloride co-treated with Folic Acid] results in decreased expression of BIRC2 mRNA CTD PMID:18156304 formaldehyde increases expression ISO RGD:1347209 6480464 Formaldehyde results in increased expression of BIRC2 mRNA CTD PMID:23649840 fucoidan decreases expression ISO RGD:1347209 6480464 fucoidan results in decreased expression of BIRC2 protein CTD PMID:16201850 furosemide affects expression EXP 6480464 Furosemide affects the expression of BIRC2 mRNA CTD PMID:17497460 gastrin-17 multiple interactions ISO RGD:1347209 6480464 [gastrin 17 co-treated with CCKBR protein] results in decreased expression of BIRC2 CTD PMID:17704804 geldanamycin multiple interactions ISO RGD:1347209 6480464 [geldanamycin co-treated with Bortezomib] results in decreased expression of BIRC2 protein CTD PMID:15781649 gemcitabine increases expression ISO RGD:1347209 6480464 gemcitabine results in increased expression of BIRC2 mRNA CTD PMID:17039268 genistein multiple interactions ISO RGD:1347209 6480464 Genistein inhibits the reaction [Oxygen deficiency results in increased expression of BIRC2 protein] CTD PMID:23452621 glutathione multiple interactions ISO RGD:1347209 6480464 Glutathione inhibits the reaction [Curcumin inhibits the reaction [TNF protein results in increased expression of BIRC2 protein]] CTD PMID:17640567 gold atom decreases expression ISO RGD:1347209 6480464 Gold results in decreased expression of BIRC2 mRNA CTD PMID:25523186 gold(0) decreases expression ISO RGD:1347209 6480464 Gold results in decreased expression of BIRC2 mRNA CTD PMID:25523186 graphite affects expression EXP 6480464 Graphite affects the expression of BIRC2 mRNA CTD PMID:29933104 guggulsterone multiple interactions ISO RGD:1347209 6480464 pregna-4 more ... CTD PMID:15322087 hemin increases expression ISO RGD:1347209 6480464 Hemin results in increased expression of BIRC2 protein CTD PMID:14647439 homocysteine decreases expression ISO RGD:1347209 6480464 Homocysteine results in decreased expression of BIRC2 mRNA, Homocysteine results in decreased expression of BIRC2 protein CTD PMID:19343037 homocysteine multiple interactions ISO RGD:1347209 6480464 Simvastatin inhibits the reaction [Homocysteine results in decreased expression of BIRC2 mRNA], Simvastatin inhibits the reaction [Homocysteine results in decreased expression of BIRC2 protein] CTD PMID:19343037 indole-3-methanol multiple interactions ISO RGD:1347209 6480464 indole-3-carbinol inhibits the reaction [TNF protein results in increased expression of BIRC2 protein] CTD PMID:15811958 indometacin multiple interactions ISO RGD:1347209 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of BIRC2 mRNA CTD PMID:28628672 isoliquiritigenin decreases expression ISO RGD:1347209 6480464 isoliquiritigenin results in decreased expression of BIRC2 protein CTD PMID:15729620 kojic acid decreases expression ISO RGD:1347209 6480464 kojic acid results in decreased expression of BIRC2 mRNA CTD PMID:16595896 leptomycin B affects localization ISO RGD:1347209 6480464 leptomycin B affects the localization of BIRC2 protein CTD PMID:15265700 linalool increases expression ISO RGD:1347209 6480464 linalool results in increased expression of BIRC2 mRNA CTD PMID:19922762 lonafarnib multiple interactions ISO RGD:1347209 6480464 lonafarnib inhibits the reaction [TNF protein results in increased expression of BIRC2 protein] CTD PMID:15090542 luteolin multiple interactions ISO RGD:1347209 6480464 Luteolin inhibits the reaction [TNF protein results in increased expression of BIRC2 protein] CTD PMID:15334063 LY294002 multiple interactions ISO RGD:1347209 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Acrolein results in increased expression of BIRC2 protein] CTD PMID:19596284 LY294002 decreases expression ISO RGD:1347209 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of BIRC2 mRNA, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of BIRC2 protein CTD PMID:12970779 more ... LY294002 multiple interactions ISO RGD:732625 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Butyrates results in increased expression of BIRC2 mRNA] CTD PMID:16256798 methoxyacetic acid multiple interactions ISO RGD:1347209 6480464 [1-aminomethylphosphonic acid co-treated with methoxyacetic acid] results in decreased expression of BIRC2 protein CTD PMID:26006246 methylseleninic acid affects expression ISO RGD:1347209 6480464 methylselenic acid affects the expression of BIRC2 mRNA CTD PMID:14617803 mitomycin C affects response to substance ISO RGD:1347209 6480464 BIRC2 protein affects the susceptibility to Mitomycin CTD PMID:16217747 mitoxantrone decreases expression ISO RGD:1347209 6480464 Mitoxantrone results in decreased expression of BIRC2 protein CTD PMID:15359644 morin decreases expression ISO RGD:1347209 6480464 morin results in decreased expression of BIRC2 mRNA CTD PMID:28689916 N-(2-aminoethyl)-5-chloroisoquinoline-8-sulfonamide multiple interactions ISO RGD:1347209 6480464 N-(2-aminoethyl)-5-chloroisoquinoline-8-sulfonamide promotes the reaction [TNFSF10 protein results in increased expression of BIRC2 protein] CTD PMID:15520213 N-acetyl-L-cysteine multiple interactions ISO RGD:1347209 6480464 Acetylcysteine inhibits the reaction [Tosylphenylalanyl Chloromethyl Ketone results in decreased expression of BIRC2 protein] CTD PMID:19679660 N-methyl-N'-nitro-N-nitrosoguanidine increases expression ISO RGD:1347209 6480464 Methylnitronitrosoguanidine results in increased expression of BIRC2 mRNA CTD PMID:12634122 N-methylformamide decreases expression ISO RGD:732625 6480464 methylformamide analog results in decreased expression of BIRC2 mRNA, methylformamide results in decreased expression of BIRC2 mRNA CTD PMID:17040096 N-tosyl-L-phenylalanyl chloromethyl ketone decreases expression ISO RGD:1347209 6480464 Tosylphenylalanyl Chloromethyl Ketone results in decreased expression of BIRC2 protein CTD PMID:19679660 N-tosyl-L-phenylalanyl chloromethyl ketone multiple interactions ISO RGD:1347209 6480464 Acetylcysteine inhibits the reaction [Tosylphenylalanyl Chloromethyl Ketone results in decreased expression of BIRC2 protein] CTD PMID:19679660 nickel sulfate increases expression ISO RGD:1347209 6480464 nickel sulfate results in increased expression of BIRC2 mRNA CTD PMID:16780908 nicotine increases expression ISO RGD:1347209 6480464 Nicotine results in increased expression of BIRC2 protein CTD PMID:20727180 nicotine multiple interactions ISO RGD:1347209 6480464 Curcumin inhibits the reaction [Nicotine results in increased expression of BIRC2 protein] CTD PMID:20727180 nitric oxide increases expression ISO RGD:732625 6480464 Nitric Oxide results in increased expression of BIRC2 protein CTD PMID:14634119 paclitaxel multiple interactions ISO RGD:1347209 6480464 [Tretinoin co-treated with Paclitaxel] results in decreased expression of BIRC2 protein, Curcumin inhibits the reaction [Paclitaxel results in increased expression of BIRC2 protein] CTD PMID:16243823 more ... paclitaxel decreases expression ISO RGD:1347209 6480464 Paclitaxel results in decreased expression of BIRC2 protein CTD PMID:14749477 more ... paclitaxel affects response to substance ISO RGD:1347209 6480464 BIRC2 protein affects the susceptibility to Paclitaxel CTD PMID:16217747 paracetamol affects expression ISO RGD:732625 6480464 Acetaminophen affects the expression of BIRC2 mRNA CTD PMID:17562736 paraquat decreases expression ISO RGD:1347209 6480464 Paraquat results in decreased expression of BIRC2 mRNA CTD PMID:18836921 Pentoxifylline multiple interactions ISO RGD:1347209 6480464 [Pentoxifylline co-treated with TNFSF10 protein] results in decreased expression of BIRC2 protein CTD PMID:20804743 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:1347209 6480464 perfluorooctane sulfonic acid results in decreased expression of BIRC2 mRNA CTD PMID:27153767 phenethyl caffeate decreases expression ISO RGD:1347209 6480464 caffeic acid phenethyl ester results in decreased expression of BIRC2 protein CTD PMID:15291876 phorbol 13-acetate 12-myristate affects localization ISO RGD:1347209 6480464 Tetradecanoylphorbol Acetate affects the localization of BIRC2 protein CTD PMID:15187025 potassium atom affects response to substance ISO RGD:1347209 6480464 BIRC2 protein affects the susceptibility to Potassium CTD PMID:9886081 progesterone increases expression EXP 6480464 Progesterone results in increased expression of BIRC2 mRNA CTD PMID:20726854 reactive oxygen species multiple interactions ISO RGD:1347209 6480464 [sanguinarine results in increased chemical synthesis of Reactive Oxygen Species] which results in decreased expression of BIRC2 protein, [Sulindac results in increased abundance of Reactive Oxygen Species] which results in decreased expression of BIRC2 protein CTD PMID:17136320 , PMID:23660334 resveratrol increases expression ISO RGD:1347209 6480464 resveratrol results in increased expression of BIRC2 mRNA CTD PMID:12569576 resveratrol decreases expression ISO RGD:1347209 6480464 resveratrol results in decreased expression of BIRC2 protein CTD PMID:11577002 more ... resveratrol multiple interactions ISO RGD:1347209 6480464 BCL2 protein inhibits the reaction [resveratrol results in decreased expression of BIRC2 protein], resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of BIRC2 protein] CTD PMID:11577002 , PMID:23452621 romidepsin multiple interactions ISO RGD:1347209 6480464 [romidepsin co-treated with Bortezomib] results in decreased expression of BIRC2 protein CTD PMID:18223231 sanguinarine multiple interactions ISO RGD:1347209 6480464 [sanguinarine results in increased chemical synthesis of Reactive Oxygen Species] which results in decreased expression of BIRC2 protein CTD PMID:23660334 selenium atom multiple interactions EXP 6480464 [Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of BIRC2 mRNA CTD PMID:11444866 semustine decreases response to substance ISO RGD:1347209 6480464 BIRC2 protein results in decreased susceptibility to Semustine CTD PMID:10815900 silicon dioxide increases expression ISO RGD:732625 6480464 Silicon Dioxide results in increased expression of BIRC2 mRNA CTD PMID:23221170 simvastatin multiple interactions ISO RGD:1347209 6480464 Simvastatin inhibits the reaction [Homocysteine results in decreased expression of BIRC2 mRNA] more ... CTD PMID:17277159 , PMID:19343037 simvastatin decreases expression ISO RGD:1347209 6480464 Simvastatin results in decreased expression of BIRC2 protein CTD PMID:18521906 sirolimus multiple interactions ISO RGD:1347209 6480464 Sirolimus inhibits the reaction [Doxorubicin results in increased expression of BIRC2 protein] CTD PMID:15571967 sirolimus increases expression EXP 6480464 Sirolimus results in increased expression of BIRC2 protein CTD PMID:21357504 sirolimus affects localization EXP 6480464 Sirolimus affects the localization of BIRC2 protein CTD PMID:21357504 sodium arsenite increases expression ISO RGD:1347209 6480464 sodium arsenite results in increased expression of BIRC2 mRNA CTD PMID:14970392 sodium fluoride decreases expression ISO RGD:1347209 6480464 Sodium Fluoride results in decreased expression of BIRC2 mRNA CTD PMID:28962382 sulindac multiple interactions ISO RGD:1347209 6480464 [Sulindac results in increased abundance of Reactive Oxygen Species] which results in decreased expression of BIRC2 protein CTD PMID:17136320 sunitinib increases expression ISO RGD:1347209 6480464 Sunitinib results in increased expression of BIRC2 mRNA CTD PMID:31533062 tephrosin multiple interactions ISO RGD:1347209 6480464 tephrosin inhibits the reaction [TNF protein results in increased expression of BIRC2 protein] CTD PMID:18841906 tetrachloromethane multiple interactions EXP 6480464 [Carbon Tetrachloride co-treated with Folic Acid] results in decreased expression of BIRC2 mRNA CTD PMID:18156304 thapsigargin decreases expression ISO RGD:1347209 6480464 Thapsigargin results in decreased expression of BIRC2 protein CTD PMID:16382148 thiophenes multiple interactions ISO RGD:1347209 6480464 Thiophenes analog promotes the reaction [Tretinoin results in increased expression of BIRC2 mRNA] CTD PMID:16140955 tioguanine decreases response to substance ISO RGD:1347209 6480464 BIRC2 protein results in decreased susceptibility to Thioguanine CTD PMID:10815900 topotecan affects response to substance ISO RGD:1347209 6480464 BIRC2 protein affects the susceptibility to Topotecan CTD PMID:16217747 tributylstannane decreases expression ISO RGD:1347209 6480464 tributyltin results in decreased expression of BIRC2 mRNA CTD PMID:27678064 venom decreases expression ISO RGD:1347209 6480464 Viper Venoms results in decreased expression of BIRC2 protein CTD PMID:25417048 vincaleukoblastine affects response to substance ISO RGD:1347209 6480464 BIRC2 protein affects the susceptibility to Vinblastine CTD PMID:16217747 vincristine increases expression ISO RGD:1347209 6480464 Vincristine results in increased expression of BIRC2 mRNA CTD PMID:23649840 vitamin E multiple interactions EXP 6480464 [Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of BIRC2 mRNA CTD PMID:11444866 vitamin E multiple interactions ISO RGD:1347209 6480464 Vitamin E inhibits the reaction [cinnamic aldehyde results in decreased expression of BIRC2 protein] CTD PMID:15566391 vorinostat multiple interactions ISO RGD:1347209 6480464 [vorinostat co-treated with TNFSF10 protein] results in decreased expression of BIRC2 protein, vorinostat inhibits the reaction [TNF protein results in increased expression of BIRC2 protein] CTD PMID:16377638 , PMID:19643600 wortmannin multiple interactions ISO RGD:1347209 6480464 wortmannin inhibits the reaction [Acrolein results in increased expression of BIRC2 protein] CTD PMID:19596284 wortmannin decreases expression ISO RGD:1347209 6480464 wortmannin results in decreased expression of BIRC2 mRNA, wortmannin results in decreased expression of BIRC2 protein CTD PMID:15065019 zerumbone decreases expression ISO RGD:1347209 6480464 zerumbone results in decreased expression of BIRC2 mRNA CTD PMID:16007145 zoledronic acid multiple interactions ISO RGD:1347209 6480464 [Tretinoin co-treated with zoledronic acid] results in decreased expression of BIRC2 mRNA CTD PMID:20349282 zoledronic acid decreases expression ISO RGD:1347209 6480464 zoledronic acid results in decreased expression of BIRC2 mRNA CTD PMID:19036117
Gene-Chemical Interaction Annotations
